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How Can We Stop Cancer?
Abstract
Cancer is a disease that humans have been struggling to combat for centuries. It originates from the
accumulation of several mutations over the life of a cell that causes it to evade cell death and multiply
rapidly. It can affect any tissue in the body and can spread to other parts of the body through metastasis.
Cancer comes in numerous shapes and sizes with different levels of aggression, growth speeds, and
health risks. Many treatments for cancer exist today, three of the most popular being surgery,
chemotherapy, and radiation therapy, which can be used in combinations with other treatments to best
fight cancer. Verma et al. (2019) showed that when surgical resection is used before chemotherapy, a
significant decrease in postoperative hospitalization lengths and 30-day mortality rates occurs, with
correlation to trends that show increased overall survival and decreased 90-day mortality rates as well.
Kim et al. (2018) approached treating surgery with a targeted therapy called anti-angiogenesis using the
prodrug TA, which provided successful results in combating cancer cells by inducing apoptosis in cancer
cells themselves as well as the endothelial cells that nourish tumors. This research can be taken into
account by oncologists and physicians when prescribing certain treatment methods in fighting cancer, as
these treatment options may have similar effects in treating and preventing other cancers, neoplastic
diseases, and infections that leach nutrients from the body.
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How Can We Stop Cancer?
Joseph R. Current
What is Cancer?
Cells are the smallest subunits of life. Some can
live on their own, while others work together to
make up multicellular organisms. Together, cells
build the tissues, organs, and organ systems that
make up a multicellular organism. Each cell
must go through the cell cycle to duplicate itself
to produce offspring. In unicellular species, this
makes up a whole other organism, but in
multicellular species, this is the way that tissues
grow. The cell cycle can be broken up into five
different phases: G1 (growth phase), S
(duplication of genetic information phase), G2
(duplication of other cellular parts), mitosis
(separation of cellular nuclei and their genetic
contents), and cytokinesis (separation of the cells
themselves).
Checkpoints exist between each phase of the cell
cycle that cells must pass to continue living.
When a cell is stopped at a checkpoint due to the
accumulation of mutations or other genetic
damage, the cell either goes through the process
to repair itself or enters another phase of the cell
cycle, called the G0 phase. In the G0 phase of
the cell cycle, the cell undergoes apoptosis, or
programmed cell death. This system keeps the
organism healthy on a cellular level by
eliminating cells that get too old or acquire too
many mutations to continue living a normal life.
Cancer is defined as a group of diseases
characterized by the uncontrollable growth and
division of cells that have accumulated a
significant number of mutations and have the
ability to spread to other parts of the body.
These cells hinder normal organ functions and
take over the nutritional and gaseous supply to a
body region. This occurs when a cell is able to
bypass the checkpoints that would normally
send it into apoptosis, which is usually caused
by a mutation(s) that a cell misses during selfassessment (National Cancer Institute, 2015, A).
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Cancer is usually categorized by size,
abnormality, and invasiveness. Not all tissues
that grow at a faster rate are considered
cancerous metastases because they are unable to
spread to other parts of the body. These growths
are called neoplasms and typically result in
benign tumors (National Cancer Institute, 2015,
A). Neoplasms can be broken down into
hyperplasias and dysplasias. When a normal
tissue exhibits signs of cell proliferation and
faster cell division, but still maintains normal
cell organization, the growth is called
hyperplasia, and usually results in a singlelayered benign tumor with the suffix “-oma;” the
prefix comes from where the tumor is found.
Dysplasia is a more serious condition because it
exhibits more abnormality and less organization
among the proliferation of cells. If the tumor the
state of dysplasia produces becomes large
enough to have multiple layers of cells, but still
doesn’t invade nearby tissues, the tumor is
called in situ. This form of neoplasm is usually
treated because it is the last version of tissue
proliferation before cancer (National Cancer
Institute, 2015, A).
Cancer occurs when tumors progress and
become invasive to nearby tissues. Invasive
tumors are typically named by their location and
the types of cells they originate in. The most
common type of cancer is a carcinoma, which
forms from epithelial cells in the body. Invasive
tumors may break off and migrate to other parts
of the body, usually by the circulatory or
lymphatic system. When this happens, the tumor
is said to be malignant, and the piece of tumor
that broke off and migrated is called a
metastasis. Malignant cancers are much more
difficult to treat because they affect multiple
parts of the body and are usually spread to an
unknown extent (National Cancer Institute,
2015, A).
History of treatment
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Since its first recognition by the ancient
philosopher and physician Hippocrates near 400
BC, many ways to treat cancer and other
neoplastic diseases have developed. Most of the
advances in cancer therapy have been developed
within the last 100 years due to breakthroughs in
technology and medicine. Oncologists - doctors
who specialize in cancer treatment - continue to
expand this field of medicine through extensive
research in strategies to fight cancer.
Surgical resection is the oldest type of treatment
for cancer. This involves the use of scalpels,
lasers, hyperthermic conditions (sometimes
using cauterization techniques for burning off
abnormal cells), photodynamic therapy (the use
of drugs activated by light that kill surrounding
tissues), or the application of liquid nitrogen or
argon gas (to freeze and destroy abnormal
tissue). Surgery usually requires the use of local,
regional, or general anesthetics to cause loss of
feeling for pain in small parts, large parts, and
the entire body, respectively. Under general
anesthesia, patients lose consciousness and
exhibit symptoms similar to a deep sleep, which
allows the surgeon to operate safely. Surgical
resection can be performed by extracting a
tumor and nearby tissues through a large cut in
open surgery, or can be done through multiple
small cuts, extracting small parts of the tumor
multiple times using tools and monitors in
minimally invasive surgery. Due to the fact that
the surgeon is unable to see the inside of the
body through small cuts in minimally invasive
surgery, they use a laparoscope (a small tube
with a tiny camera on it to project video of the
inside of the body to a monitor for the surgeon
to see) to complete the resection. Minimally
invasive surgery requires less time to recover
because smaller incisions are used than during
open surgery, which tend to heal at a faster rate.
Surgical resection can also be performed for
multiple purposes: curative surgery aims to
remove the entire tumor to cure the patient of
cancer; preventive surgery involves the removal
of tissue that has the potential to become cancer,
such as dysplasia or in-situ tumor; diagnostic
resection takes one part of a cell growth out of
the body to study for cancerous properties;
debulking resection extracts a large part of a
tumor to minimize its size; palliative care
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includes the use of surgery to ease pain caused
by cancer; supportive therapy aims to help other
cancer treatments work more effectively;
restorative surgery is used to rebuild a patient’s
body through plastic surgery to restore normal
bodily characteristics (National Cancer Institute,
2015, B). Marinho et al. (2018) performed a
study that recorded cancer patients’ qualities of
life before surgery and quality of recovery after,
finding 31 out of 138 surveyed patients having
poor quality of recovery. Patients who had a
poor quality of recovery also had significantly
poor qualities of life, frailness, and high cardiac
risk factors, which are all characteristics that
oncologists need to consider when
recommending surgical resection as a treatment
for cancer. Despite this, surgical resection
remains the preferred treatment type because of
its diversity, conformity, and ability to be used
in conjunction with other methods to treat
cancer.
Chemotherapy, or chemo, is the second most
common way to treat cancer. It involves the use
of drugs to stop or slow cancer growth. This can
help oncologists treat cancer by curing it,
lessening its chance of return, or reducing the
size of tumors that cause pain or other
symptoms. Chemotherapy is typically used in
conjunction with other forms of therapy. When
it is used before another form of treatment
(mainly to decrease the size of a tumor), it is
called neoadjuvant chemotherapy. Conversely,
adjuvant chemotherapy is defined as
chemotherapy used after another form of cancer
treatment. It can be administered in a multitude
of ways depending on cancer type, drug
conformity, and medicinal accessibility: oral (by
mouth), intravenous (directly into a vein),
injection (by a hypodermic needle), or topically
(by rubbing it into the skin). Chemotherapy is a
non-invasive treatment but has other side effects
because it does not differentiate between healthy
and cancer cells. This typically affects normal
cells in the body that divide fast, such as cells
that make up hair and the linings of the mouth,
stomach, and intestine, causing hair loss, mouth
sores, ulcers, and nausea. Fatigue is another side
effect common with chemotherapy treatment
because healthy body cells slow their rates of

2

Current: How Can We Stop Cancer?

activity and do not perform at optimal metabolic
capacities (National Cancer Institute, 2015, C).
Another common way to treat cancer is through
radiation therapy, or radiotherapy. This is the
exposure of the body to high levels of radiation
to reduce tumor sizes and destroy cancer cells.
Radiation therapy can be performed by using an
external beam of radiation to deliver
concentrated doses of radiation to a localized
area or by using an internal source of radiation.
External beam radiation can be delivered by two
methods: conventionally fractionated radiation
therapy and stereotactic ablative radiation
therapy. Conventionally fractionated radiation
therapy uses a broad, low-powered beam of
radiation administered in multiple doses to
destroy cancer cells while stereotactic ablative
radiation therapy involves the use of a highly
accurate, high-powered, concentrated beam of
radiation to eliminate cancer cells (National
Cancer Institute, 2015, D). Verma et al. (2018)
concluded that no significant difference exists in
the overall survival rates between patients who
received either treatment for inoperable stage I
small cell lung cancer. Although, stereotactic
ablative radiation therapy is the favored external
form of radiotherapy because it is more costeffective, conformative, and convenient than
conventionally fractionated radiation therapy
while producing relatively equal results of
treatment. On the other hand, internal radiation
therapy also has two forms: brachytherapy and
systemic radiation therapy. Brachytherapy uses a
solid source of radiation that is implanted in the
body near or in the tumor to release radiation
over time, while systemic radiation therapy
involves the introduction of a radioactive liquid
into the system through ingestion, hypodermal
injection, or intravenous solution, to travel
through the blood to reach and destroy cancer
cells. Radiation therapy is very similar to
chemotherapy in regards to side effects,
frequency of being combined with other
treatments, and that it also affects healthy tissues
within the area of treatment, but is different in
that it has the ability to be more localized and is
associated with lifetime dose limits to avoid the
development of other health issues in areas that
are treated with radiation more than once
(National Cancer Institute, 2015, D).
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Among the three main ways to treat cancer
described above, many other treatment options
exist that are relatively new. Immunotherapy is a
cancer treatment that aids the immune system in
battling cancer. Targeted therapy treats cancer
by targeting its methods of growing, dividing,
and spreading. Hormonal therapy blocks the
body’s ability to produce hormones that some
cancers use to grow. Virotherapy uses oncolytic
viruses that have had their virulence factors
removed to attack cancer cells while ignoring
normal cells (National Cancer Institute, 2015,
E). Virotherapy works very well when paired
with immunotherapy because defects in immune
signaling within tumors can be used for
oncolytic viruses to target for destruction and
self-replication (Kadia, 2016). Another
supportive treatment of cancer includes stem cell
transplants, which replace the stem cells in a
patient’s body that have been destroyed by other
treatments (National Cancer Institute, 2015, E).
Cancer treatments are constantly being
developed and tested by oncologists around the
world in the international fight against cancer.
As with any disease, one of the most effective
ways to combat cancer is to prevent it. A
scientific review published by Colditz et al.
(2012) shows the potential for our society to
prevent cancer to be at a level that could cut
cancer cases by more than half (54.5%). Ways to
prevent cancer include quitting smoking,
implementing healthier diets, increasing
exercise, avoiding obesity, acquiring
vaccinations against cancer-causing viruses,
avoiding UV and other ionizing radiation,
decreasing irresponsible consumption of alcohol
and prescription medications, and decreasing
pollution. Obstacles for the success of such
prevention include societal skepticism of the
preventability of cancer, the lack of research in
cancer prevention (rather than treatment), and
the absence of an infrastructure that can be held
accountable to educate the public.
In this work, I examine and review studies that
address the different treatments to help cure the
family of diseases called cancer and keep it from
returning. Using an approach that compares
overall survival rates, postoperative
hospitalization lengths, 30/90-day mortality
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rates, and 30-day readmission rates between
cancer patients treated with induction
chemotherapy and then surgical resection versus
up-front resection followed by postoperative
chemotherapy, Verma et al. (2019) showed that
patients who received up-front surgical resection
followed by postoperative chemotherapy had
significantly shorter postoperative
hospitalization and lower 30-day mortality, as
well as correlation to increased median overall
survival and decreased 90-day mortality. In
addition, Kim et al. (2018) used targeted therapy
through the injection of a hypoxia-responsive,
anti-angiogenic prodrug (TA) into strains of
normal and cancerous cells under normoxic and
hypoxic conditions in vitro to show that, when
activated in hypoxic cancer cells, TA causes a
reduction in topoisomerase I, COX-2, and
VEGF gene expression, leading to significantly
increased toxicity and decreased cancer cell
viability while normal cells were left relatively
unaffected. Taken together, these studies both
contribute to the eradication of cancer and
suggest successful ways to fight and end cancer,
as well as other neoplastic diseases, while
increasing overall survivability for patients.
R/PC may be a more successful combination
of treatment methods
In the past 50 years, it has become very common
for surgical resection and chemotherapy to be
used together to treat cancer. If neoadjuvant
chemotherapy is administered before surgery,
the treatment combination is called induction
chemotherapy followed by surgical resection,
which is regularly abbreviated as IC/R.
Advantages of this method would be having the
ability to reduce the size of a tumor before its
extraction, which also may minimize how
invasive the surgery after chemo is. Up-front
resection followed by postoperative
chemotherapy, or R/PC treatment, involves the
use of adjuvant chemotherapy after surgical
resection. The advantages of this procedure
include the ability to prevent cancer from
returning using chemotherapy after the surgery
removes the majority - if not the entirety - of the
tumor. In addition, it is more typical to provide
weaker, less harmful chemotherapy medication
in R/PC treatment than in IC/R treatment
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because IC/R treatment relies more heavily on
the use of chemotherapy to remove cancerous
tissue (Verma 2019).
To determine the best treatment or combination
of treatments to fight cancer, Verma et al.
(2019) examined the data for two different
combinations of treatments for patients with
malignant pleural mesothelioma (IC/R and
R/PC). Malignant pleural mesothelioma is an
aggressive and deadly form of cancer that
resides in the mesothelium, which is a thin layer
of tissue that covers most internal organs in the
thoracic and abdominal cavities. It is caused by
the inhalation and migration of asbestos fibers
from the air to the pleural lining, causing
inflammation, tissue damage, and scarring.
Since asbestos is considered a carcinogen, it has
the capacity to cause mutations in the tissues
that are exposed to it, posing a greater risk for
the development of cancer. In addition, the
asbestos can also cause nearby tissues to have
similar symptoms to those of the mesothelium
and trigger the development of cancers in the
lung, peritoneum, and pericardium. Comparative
analysis techniques were used to study the
overall survival rates, lengths of postoperative
hospitalization, 30/90-day mortality rates, and
30-day readmission rates between IC/R and
R/PC treated patients that were documented in
the National Cancer Database.
Of the 361 malignant pleural mesothelioma
patients, 182 were treated using IC/R and 179
were treated using R/PC techniques. R/PC
patients were found to have a correlation to
increased median overall survival and decreased
90-day mortality rates. In addition, R/PC
patients had significantly decreased
postoperative hospitalization lengths (6 days vs.
7 days, p = 0.001) and 30- day mortality rates
(0.0% vs. 3.3%, p = 0.020) on 95% confidence
intervals. There was no statistical difference in
30-day readmission rates for patients between
each treatment combination. Therefore, R/PC is
a more successful treatment combination than
IC/R for treating malignant pleural
mesothelioma (Verma 2019), and may show
increased success in treating similar cancers.
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Anti-angiogenic prodrugs significantly
decrease Cancer viability
The circulatory system is a vital body system in
multicellular organisms. It serves many
functions, including the transport of nutrients,
ions, gases, metabolites, and metabolic wastes
around the body through blood vessels.
Angiogenesis is the formation of blood
vasculature throughout the various tissues of our
body to aid in the delivery and removal of the
molecules that are vital to many life processes. It
is stimulated by growth factors and hormones
throughout the development of an organism to
maintain vascular coverage through the entirety
of the body. This is important to prevent the
starvation or buildup of toxic substances in local
areas of the body. Without the circulatory
system, the internal cells of many multicellular
organisms would never acquire essential
molecules for life and, in turn, would starve or
accumulate metabolic wastes that would not be
transported away from internal tissues.
As with any body cell, cancer cells need vital
nutrients essential to life to continue to grow and
divide. They also require the removal of waste
products. To grow inside a multicellular
organism, tumors must acquire nutrients and get
rid of metabolic wastes using blood vessels.
They attract blood vessels and induce
angiogenesis by releasing a growth factor called
VEGF (vascular endothelial growth factor). This
growth factor stimulates the formation of new
vasculature towards the tumor and capillaries to
grow around it. The constant flow of nutrient,
oxygen-filled blood to the tumor allows it to
obtain nutrients from the body to grow and
divide. The blood also cleanses the cancer cells
by removing metabolic waste buildup, further
supporting it. Finally, blood vessels that connect
to the tumor provide a route for the tumor to
metastasize and travel to other parts of the body
and form other cancerous growths (Kim 2018).
Anti-angiogenesis is a form of targeted therapy
that aims to starve cancerous tumors by cutting
off their supply lines, inhibiting angiogenesis
locally to prevent tumors from siphoning
nutrients and oxygen from the body and leaving
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it with metabolic wastes. Like
chemotherapy/radiation therapy, many
chemicals involved with anti-angiogenic therapy
are toxic to neighboring normal cells (Wang
2015). Kim et al. (2018) employed antiangiogenic techniques to destroy cancer cells in
their experiment by injecting a hypoxia-induced,
anti-angiogenic prodrug (denoted as TA) into
strains of normal and cancerous cells under
normoxic (21% O2) and hypoxic (1% O2)
conditions in vitro. They observed the
differences in cell viability (by cytotoxicity) and
gene expression levels to determine the effect
TA had on the injected tissues.
Under hypoxic conditions (when TA becomes
active), the gene expression of topoisomerase I,
COX-2, and VEGF was decreased in cancer
cells. This contributes to the apoptosis of cancer
cells themselves and the vascular tissue
surrounding the tumor. Topoisomerase I is a
protein that aids in the rewinding of DNA during
replication, and without it, cancer cells aren’t
able to live, grow, and divide. Therefore,
decreased levels of topoisomerase I show that
TA contributes to cell death in cancer cells when
activated by hypoxic conditions. In addition,
COX- 2 (a gene associated with inflammation
and vascular growth) and VEGF (growth factor
associated with vascular development) also
exhibited decreased levels in hypoxic conditions
when exposed to TA, supporting the idea that TA
contributes to anti-angiogenesis. Other data from
Kim’s experiment suggest that TA only produces
lethal effects in hypoxic cancer cells, not
harming hypoxic normal cells in any significant
way. Hypoxic cancer cells significantly dropped
in viability from 100% to 40% with just a 10
micromolar concentration of TA, as well as
decreasing by a factor of two with each
incremental increase in TA concentration, while
hypoxic normal cells only decreased to a
minimum of 90% viability (p < 0.05). In this
experiment, TA shows that it is successful in
combating cancer using its apoptotic and antiangiogenic effects on cancer cells while leaving
normal cells virtually untouched (Kim 2018).
This may also hold true in human cancers, and
should be explored more.
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The most successful ways to combat cancer
Cancer is a disease that humans have been
struggling to combat for centuries. Recently, the
treatments that have already been developed by
oncologists to fight cancer have been used in
combinations with other treatments to best fight
cancer. This popular treatment method
implements the use of drug cocktails and
multiple treatment plans to attack cancer through
various mediums. Verma et al. (2019) showed
that when surgical resection is used before
chemotherapy, a significant decrease in
postoperative hospitalization lengths and 30-day
mortality rates occurs, with correlation to trends
that show increased overall survival and
decreased 90-day mortality rates as well. This
type of study helps oncologists and physicians
decide what the best combination of treatment
options is so an educated decision can be made
before choosing to randomly mix multiple
therapies.

from the body, as these treatment options may
have similar effects in treating and preventing
these types of medical issues. Studies like these
promote the use of Western medicine and
support the advancement of our biological and
medical understanding of the human body.

Research into novel treatment methods is very
important as well. Kim et al. (2018) approached
treating surgery with a new targeted therapy
involving anti-angiogenesis using the prodrug
TA, which provided successful results in
combating cancer cells in vitro by inducing
apoptosis in cancer cells themselves as well as
the blood vasculature that nourishes tumors.
This experiment was very significant for the
development of this new therapy type, which
will be very helpful if/when approved for testing
in vivo in human bodies someday. Since no
universal intervention exists for all cancers yet,
research into new ways to destroy cancer is
conducive to the progression of the field of
study. When paired with other new or old
treatment methods, novel therapies like antiangiogenesis could someday lead oncologists to
the cure for cancer.
Lastly, the results from the aforementioned
studies, along with the findings of other
oncological researchers, can be taken into
account by physicians and oncologists when
prescribing certain treatment methods or
combinations for treating cancers, neoplastic
diseases, or other infections that leach nutrients
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